SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

FERRER, M. et al. Nuevas formas farmacéuticas para el tratamiento de enfermedades alérgicas. Anales Sis San Navarra [online]. 2012, vol.35, n.1, pp.41-51. ISSN 1137-6627.  http://dx.doi.org/10.4321/S1137-66272012000100005.

    1. Kuschner WG. The asthma epidemic. N Engl J Med 2007; 356: 1073. [ Links ]

    2. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743. [ Links ]

    3. Fernandez Rivas M. Food allergy in Alergologica-2005. J Investig Allergol Clin Immunol 2009; 19 (Suppl. 2): 37-44. [ Links ]

    4. Navarro A, Colas C, Anton E, Conde J, Davila I, Dordal MT et al. Epidemiology of allergic rhinitis in allergy consultations in Spain: Alergologica-2005. J Investig Allergol Clin Immunol 2009; 19 (Suppl. 2): 7-13. [ Links ]

    5. Radulovic SCM, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2010; CD002893. [ Links ]

    6. Calderon MA AB, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007; CD001936. [ Links ]

    7. Tsitoura DC, Tassios Y. Immunomodulation: the future cure for allergic diseases. Ann N Y Acad Sci 2006; 1088: 100-115. [ Links ]

    8. Fonseca DE KJ. Use of CpG oligonucleotides in treatment of asthma and allergic disease. Adv Drug Deliv Rev. 2009; 61: 256-262. [ Links ]

    9. Sheikh NA, al-Shamisi M, Morrow WJ. Delivery systems for molecular vaccination. Curr Opin Mol Ther 2000; 2: 37-54. [ Links ]

    10. Clements CJ, Griffiths E. The global impact of vaccines containing aluminium adjuvants. Vaccine 2002; 20 (Suppl. 3): S24-S33. [ Links ]

    11. Francis MJ, Fry CM, Rowlands DJ, Bittle JL, Houghten RA, Lerner RA et al. Immune response to uncoupled peptides of foot-and-mouth disease virus. Immunology 1987; 61: 1-6. [ Links ]

    12. Kwissa M, Lindblad EB, Schirmbeck R, Reimann J. Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response. J Mol Med (Berl) 2003; 81: 502-510. [ Links ]

    13. Schijns V E. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 2000; 12: 456-63. [ Links ]

    14. O´Hagan DT, Valiante NM. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov 2003; 2: 727-735. [ Links ]

    15. Kersten G, Hirschberg H. Antigen delivery systems. Expert Rev Vaccines 2004; 3: 453-462. [ Links ]

    16. Ulmer JB. Enhancement of vaccine potency through improved delivery. Expert Opin Biol Ther 2004; 4: 1045-1051. [ Links ]

    17. Calderon MA, Penagos M, Sheikh A, Canonica GW, Durham S. Sublingual immunotherapy for treating allergic conjunctivitis. Cochrane Database Syst Rev 2011; CD007685. [ Links ]

    18. Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy 2011; 66: 740-752. [ Links ]

    19. Enrique E, Pineda F, Malek T, Bartra J, Basagana M, Tella R et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005; 116: 1073-1079. [ Links ]

    20. Fernández-Rivas M, Garrido Fernandez S, Nadal JA, Diaz de Durana MD, García BE, Gonzalez-Mancebo E et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009; 64: 876-883. [ Links ]

    21. Gómez S, Gamazo C, San Román B, Vauthier C, Ferrer M, Irache JM. Developement of a novel vaccine delivery system based on Gantrez nanoparticles. J Nanosci Nanotechnol 2006; 6: 3283-3289. [ Links ]

    22. Rice-Ficht AC, Arenas-Gamboa AM, Kahl-McDonagh MM, Ficht TA. Polymeric particles in vaccine delivery. Curr Opin Microbiol 2010; 13: 106-112. [ Links ]

    23. Chadwick S, Kriegel C, Amiji M. Nanotechnology solutions for mucosal immunization. Adv Drug Deliv Rev 2010; 62: 394-407. [ Links ]

    24. Zolnik BS, Gonzalez-Fernandez A, Sadrieh N, Dobrovolskaia MA. Nanoparticles and the immune system. Endocrinology 2010; 151: 458-465. [ Links ]

    25. Wilson KD, de Jong SD, Tam YK. Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy. Adv Drug Deliv Rev 2009; 61: 233-242. [ Links ]

    26. Altin JG, Parish CR. Liposomal vaccines--targeting the delivery of antigen. Methods 2006; 40: 39-52. [ Links ]

    27. Dow S. Liposome-nucleic acid immunotherapeutics. Expert Opin Drug Deliv 2008; 5: 11-24. [ Links ]

    28. Tovey MG, Lallemand C. Adjuvant activity of cytokines. Methods Mol Biol 2010; 626: 287-309. [ Links ]

    29. Gamvrellis A, Leong D, Hanley JC, Xiang SD, Mottram P, Plebanski M. Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 2004; 82: 506-516. [ Links ]

    30. Singh M, Chakrapani A, O´Hagan D. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines 2007; 6: 797-808. [ Links ]

    31. Scholl I, Weissenbock A, Forster-Waldl E, Untersmayr E, Walter F, Willheim M et al. Allergen-loaded biodegradable poly (D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model. Clin Exp Allergy 2004; 34: 315-321. [ Links ]

    32. Batanero E, Barral P, Villalba M, Rodríguez R. Encapsulation of Ole e 1 in biodegradable microparticles induces Th1 response in mice: a potential vaccine for allergy. J Control Release 2003; 92: 395-398. [ Links ]

    33. Ropert C, Malvy C, Couvreur P. Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action. Pharm Res 1993; 10: 1427-1433. [ Links ]

    34. O´Hagan DT, Rappuoli R. Novel approaches to vaccine delivery. Pharm Res 2004; 21: 1519-1530. [ Links ]

    35. Singh M, O´Hagan D T. Recent advances in vaccine adjuvants. Pharm Res 2002; 19: 715-728. [ Links ]

    36. Alvarez MJ, Echechipia S, Garcia B, Tabar AI, Martin S, Rico P et al. Liposome-entrapped D. pteronyssinus vaccination in mild asthma patients: effect of 1-year double-blind, placebo-controlled trial on inflammation, bronchial hyperresponsiveness and immediate and late bronchial responses to the allergen. Clin Exp Allergy 2002; 32: 1574-1582. [ Links ]

    37. Basomba A, Tabar AI, de Rojas DH, Garcia BE, Alamar R, Olaguibel J M et al. Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients. J Allergy Clin Immunol 2002; 109: 943-948. [ Links ]

    38. Spenlehauer G, Spenlehauer-Bonthonneau F, Thies C. Biodegradable microparticles for delivery of polypeptides and proteins. Prog Clin Biol Res 1989; 292: 283-291. [ Links ]

    39. Arbos P, Wirth M, Arangoa M A, Gabor F, Irache J M. Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates. J Control Release 2002; 83: 321-330. [ Links ]

    40. San Roman B, Irache JM, Gomez S, Gamazo C, Espuelas S. Co-Delivery of Ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis. Int Arch Allergy Immuno 2009; 149: 111-118. [ Links ]

    41. San Roman B, Irache JM, Gomez S, Tsapis N, Gamazo C, Espuelas MS. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology. Eur J Pharm Biopharm 2008; 70: 98-108. [ Links ]

    42. Gómez S, Gamazo C, Roman BS, Ferrer M, Sanz ML, Irache JM, Gantrez AN. Nanoparticles as an adjuvant for oral immunotherapy with allergens. Vaccine 2007; 25: 5263-5271. [ Links ]

    43. Gómez S, Gamazo C, San Roman B, Grau A, Espuelas S, Ferrer M et al. A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne. J Immunol Methods 2009; 348: 1-8. [ Links ]

    44. Lack G. Clinical practice. Food allergy. N Engl J Med 2008; 359: 1252-1260. [ Links ]

    45. de Silva IL, Mehr SS, Tey D, Tang ML. Paediatric anaphylaxis: a 5 year retrospective review. Allergy 2008; 63: 1071-1076. [ Links ]

    46. Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW. Successful oral tolerance induction in severe peanut allergy. Allergy 2009; 64: 1218-1220. [ Links ]

    47. Sheikh A, Nurmatov U, Venderbosch I, Bischoff E. Oral immunotherapy for the treatment of peanut allergy: systematic review of six case series studies. Prim Care Respir J 2011; 21: 41-49. [ Links ]